Harbour Biomed: Funding, Investors & Team (Sep 2026)
Harbour BioMed is a developer of bio-therapeutics aimed at immuno-oncology and inflammatory diseases. The company engages in discovery and development programs that are centered around two patented transgenic mouse platforms for generating both fully human monoclonal antibodies (H2L2) and heavy chain only antibodies (HCAb) based immune cell engager (HBICETM) bispecific antibodies, thereby enabling medical professionals to generate potential therapeutic antibodies and accelerate drug discovery and development.
Harbour Biomed has raised $103M across 1 funding round on record, the most recent an undisclosed round of $103M announced in Jul 2020.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Harbour Biomed Company Profile and Key Stats
Latest funding round on record: Jul 2020.
Harbour Biomed Funding Rounds
Harbour Biomed Founders and Leadership Team
No contact details are on record for this team yet.
Harbour Biomed Funding Compared to Other Biotechnology Startups
Harbour Biomed's latest round of $103M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Harbour Biomed in Biotechnology and Shanghai
Companies Similar to Harbour Biomed
Protoga is a biotech firm that focused on the development of innovative microalgae biosynthesis technology.
Yuantian Bio is a biotechnology company specializing in enzymatic regeneration and commercial plastic PET…
NewLine researches phage feed additives to prevent livestock infections.
Echo Biotech is a biotech firm mainly engaged in the R&D and production of exosome molecular diagnostic…
Salus BioMed is an innovative biomedical company that specializes in developing genetic sequencing technology…
Epigenic Therapeutics is a drug development company that develops gene modulation therapies through the…
CANbridge Pharmaceuticals is a bio-pharmaceutical company accelerating development and commercialization of…
JW Therapeutics is a developer of cell-based therapy technologies created to revolutionize cancer…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
MAASH is a biotech mycoprotein producing company that supply a nutritious and health feed and food protein…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Adaptyv Biosystems developing a protein engineering platform using cell-free synthetic biology and…
Harbour Biomed Funding FAQs
What does Harbour Biomed do?
Harbour BioMed is a developer of bio-therapeutics aimed at immuno-oncology and inflammatory diseases. The company engages in discovery and development programs that are centered around two patented transgenic mouse platforms for generating both fully human monoclonal antibodies (H2L2) and heavy chain only antibodies (HCAb) based immune cell engager (HBICETM) bispecific antibodies, thereby enabling medical professionals to generate potential therapeutic antibodies and accelerate drug discovery and development.
How much funding has Harbour Biomed raised?
Harbour Biomed has raised $103M across 1 round on record. The most recent is an undisclosed round of $103M announced in Jul 2020.
When did Harbour Biomed last raise funding?
Harbour Biomed's most recent funding round on record is an undisclosed round of $103M, announced in Jul 2020.
Who is the CEO of Harbour Biomed?
Jingsong Wang is listed as CEO at Harbour Biomed.
Where is Harbour Biomed headquartered?
Harbour Biomed is based in Shanghai, China.
How many employees does Harbour Biomed have?
Harbour Biomed is in the 51-100 employee band.
How does Harbour Biomed's funding compare to other Biotechnology startups?
Harbour Biomed's latest round of $103M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Harbour Biomed Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Harbour Biomed is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.